Cointime

Sirigen

company

About

Sirigen develops light harvesting materials delivering high sensitivity fluorescence for the early detection of life threatening diseases.

  • 11 - 50

Highlights

Total Funding Amount
$3M £3.83M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$3M
Industries
Biotechnology,Health Diagnostics,Therapeutics
Founded date
Jan 1, 2003
Number Of Employee
11 - 50
Operating Status
Active

Harnessing the power of novel light-harvesting polymeric materials, Sirigen’s amplification technology offers High Sensitivity Fluorescence™ (HSF™) detection to the Diagnostic and Life Science marketplaces.

Sirigen’s versatile and HSF™ technology simplifies sample processing and instrumentation requirements in both immunodiagnostic and nucleic acid based applications, and facilitates high volume screening in theradiagnostics and other personal care applications.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$3M £3.83M
Sirigen has raised a total of $3M £3.83M in funding over 2 rounds. Their latest funding was raised on Oct 25, 2011 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Oct 25, 2011 Series Unknown $3M 1 — — Detail
Oct 1, 2010 Series Unknown £3.83M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
2
Sirigen is funded by 2 investors. British Smaller Technology Companies VCT 2 and Persistence Partners are the most recent investors.
Investor Name Lead Investor Funding Round
British Smaller Technology Companies VCT 2 — Series Unknown
Persistence Partners — Series Unknown
Cointime
เนื้อหา
บริษัท